Melani, A.; Papini, G.; Bonaso, M.; Biso, L.; Kolachalam, S.; Bragazzi, N.L.; Conversano, C.; Orrù, G.; Longoni, B.; Scarselli, M.
Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind. Biomedicines 2026, 14, 506.
https://doi.org/10.3390/biomedicines14030506
AMA Style
Melani A, Papini G, Bonaso M, Biso L, Kolachalam S, Bragazzi NL, Conversano C, Orrù G, Longoni B, Scarselli M.
Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind. Biomedicines. 2026; 14(3):506.
https://doi.org/10.3390/biomedicines14030506
Chicago/Turabian Style
Melani, Alice, Giorgia Papini, Marco Bonaso, Letizia Biso, Shivakumar Kolachalam, Nicola Luigi Bragazzi, Ciro Conversano, Graziella Orrù, Biancamaria Longoni, and Marco Scarselli.
2026. "Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind" Biomedicines 14, no. 3: 506.
https://doi.org/10.3390/biomedicines14030506
APA Style
Melani, A., Papini, G., Bonaso, M., Biso, L., Kolachalam, S., Bragazzi, N. L., Conversano, C., Orrù, G., Longoni, B., & Scarselli, M.
(2026). Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind. Biomedicines, 14(3), 506.
https://doi.org/10.3390/biomedicines14030506
